In addition, researchers demonstrated that ZEB1-AS1 deficiency drastically reduces ZEB1 content by up-regulating miR-129-5p, which, ultimately enhances drug sensitivity to cisplatin in BC [45]. Here, ZEB1 is linked to breast cancer.